-
Something wrong with this record ?
Novel presentation of the c.1856A > G (p.Asp619Gly) TSHR gene-activating variant: relapsing hyperthyroidism in three subsequent generations manifesting in early childhood and an in vitro functional study
M. Bezdicka, P. Kleiblova, J. Soucek, M. Borecka, E. El-Lababidi, D. Smrz, M. Rataj, Z. Sumnik, J. Malikova, O. Soucek
Language English Country Switzerland
Document type Case Reports, Journal Article, Review
Grant support
00064203
Ministerstvo Zdravotnictví Ceské Republiky
NU20-03-00285
Ministerstvo Zdravotnictví Ceské Republiky
CZ.1.05/4.1.00/16.0337
Ministerstvo Školství, Mládeže a Tělovýchovy
- MeSH
- Graves Disease * MeSH
- Hyperthyroidism * genetics MeSH
- Humans MeSH
- Neoplasm Recurrence, Local MeSH
- Child, Preschool MeSH
- Iodine Radioisotopes MeSH
- Receptors, Thyrotropin genetics metabolism MeSH
- Thyroglobulin chemistry MeSH
- Antithyroid Agents pharmacology MeSH
- Thyrotropin chemistry MeSH
- Thyroxine metabolism MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Child, Preschool MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Review MeSH
BACKGROUND: Familial non-autoimmune hyperthyroidism is a rare disease caused by germline activating variants in the thyroid-stimulating hormone receptor (TSHR) gene. The c.1856A > G (p.Asp619Gly) pathogenic variant has been described in cases of toxic adenoma but never before, to our knowledge, in a case of familial non-autoimmune hyperthyroidism. PATIENT FINDINGS: A 3-year-old boy was admitted for acute gastroenteritis presenting with goiter and tall stature. Laboratory findings revealed peripheral hyperthyroidism and negativity for thyroid autoantibodies. Antithyroid drug treatment was effective, but relapses occurred shortly after attempts to decrease the drug dose. As the boy's father and paternal grandmother also experienced relapsing hyperthyroidism manifesting in early childhood, genetic testing of TSHR was indicated. The c.1856A > G (p.Asp619Gly) pathogenic variant was found in all three affected family members. Functional in vitro characterization of the variant verified that it enhances constitutional activation of the receptor, leading to increased production of cyclic adenosine monophosphate. Total thyroidectomy was indicated in the boy due to an unsatisfactory prognosis. Due to persistent positive thyroglobulin serum concentration, a diagnostic radioiodine scan was performed approximately 2 years later. Residual thyroid tissue was revealed; therefore, radioiodine ablative therapy was performed. Despite adequate thyroxine substitution over a long period of follow-up, TSH remained suppressed. CONCLUSIONS: Unlike Graves' disease, familial non-autoimmune hyperthyroidism cases present with antithyroid drug-dependence. Not ultrasound but positive thyroglobulin serum concentration indicated residual thyroid tissue. Early detection of residual thyroid tissue and radioiodine ablation prevented the subject from experiencing relapsing hyperthyroidism and undergoing unnecessary repeated surgery. Life-long hormone substitution should be adjusted to free thyroxine rather than TSH serum concentrations.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22011816
- 003
- CZ-PrNML
- 005
- 20230712141803.0
- 007
- ta
- 008
- 220425s2021 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s42000-021-00299-x $2 doi
- 035 __
- $a (PubMed)34142359
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Bezdicka, Martin $u Vera Vavrova Laboratory/VIAL, Department of Pediatrics, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 245 10
- $a Novel presentation of the c.1856A > G (p.Asp619Gly) TSHR gene-activating variant: relapsing hyperthyroidism in three subsequent generations manifesting in early childhood and an in vitro functional study / $c M. Bezdicka, P. Kleiblova, J. Soucek, M. Borecka, E. El-Lababidi, D. Smrz, M. Rataj, Z. Sumnik, J. Malikova, O. Soucek
- 520 9_
- $a BACKGROUND: Familial non-autoimmune hyperthyroidism is a rare disease caused by germline activating variants in the thyroid-stimulating hormone receptor (TSHR) gene. The c.1856A > G (p.Asp619Gly) pathogenic variant has been described in cases of toxic adenoma but never before, to our knowledge, in a case of familial non-autoimmune hyperthyroidism. PATIENT FINDINGS: A 3-year-old boy was admitted for acute gastroenteritis presenting with goiter and tall stature. Laboratory findings revealed peripheral hyperthyroidism and negativity for thyroid autoantibodies. Antithyroid drug treatment was effective, but relapses occurred shortly after attempts to decrease the drug dose. As the boy's father and paternal grandmother also experienced relapsing hyperthyroidism manifesting in early childhood, genetic testing of TSHR was indicated. The c.1856A > G (p.Asp619Gly) pathogenic variant was found in all three affected family members. Functional in vitro characterization of the variant verified that it enhances constitutional activation of the receptor, leading to increased production of cyclic adenosine monophosphate. Total thyroidectomy was indicated in the boy due to an unsatisfactory prognosis. Due to persistent positive thyroglobulin serum concentration, a diagnostic radioiodine scan was performed approximately 2 years later. Residual thyroid tissue was revealed; therefore, radioiodine ablative therapy was performed. Despite adequate thyroxine substitution over a long period of follow-up, TSH remained suppressed. CONCLUSIONS: Unlike Graves' disease, familial non-autoimmune hyperthyroidism cases present with antithyroid drug-dependence. Not ultrasound but positive thyroglobulin serum concentration indicated residual thyroid tissue. Early detection of residual thyroid tissue and radioiodine ablation prevented the subject from experiencing relapsing hyperthyroidism and undergoing unnecessary repeated surgery. Life-long hormone substitution should be adjusted to free thyroxine rather than TSH serum concentrations.
- 650 _2
- $a thyreostatika $x farmakologie $7 D013956
- 650 _2
- $a předškolní dítě $7 D002675
- 650 12
- $a Gravesova nemoc $7 D006111
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a hypertyreóza $x genetika $7 D006980
- 650 _2
- $a radioizotopy jodu $7 D007457
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lokální recidiva nádoru $7 D009364
- 650 _2
- $a receptory thyreotropinu $x genetika $x metabolismus $7 D011989
- 650 _2
- $a thyreoglobulin $x chemie $7 D013954
- 650 _2
- $a thyreotropin $x chemie $7 D013972
- 650 _2
- $a thyroxin $x metabolismus $7 D013974
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Kleiblova, Petra $u Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Soucek, Jiri $u Private Paediatric Endocrinology Practice, Carlsbad, Czech Republic
- 700 1_
- $a Borecka, Marianna $u Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $u Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a El-Lababidi, Eva $u Department of Pediatrics, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic
- 700 1_
- $a Smrz, Daniel $u Department of Immunology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Rataj, Michal $u Department of Immunology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Sumnik, Zdenek $u Department of Pediatrics, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Křenek Malíková, Jana $u Department of Pediatrics, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic $7 xx0158263
- 700 1_
- $a Soucek, Ondrej $u Vera Vavrova Laboratory/VIAL, Department of Pediatrics, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic. Ondrej.Soucek@lfmotol.cuni.cz $u Department of Pediatrics, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic. Ondrej.Soucek@lfmotol.cuni.cz $1 https://orcid.org/0000000265551802
- 773 0_
- $w MED00007137 $t Hormones $x 2520-8721 $g Roč. 20, č. 4 (2021), s. 803-812
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34142359 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20230712141805 $b ABA008
- 999 __
- $a ok $b bmc $g 1789427 $s 1163015
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 20 $c 4 $d 803-812 $e 20210618 $i 2520-8721 $m Hormones $n Hormones $x MED00007137
- GRA __
- $a 00064203 $p Ministerstvo Zdravotnictví Ceské Republiky
- GRA __
- $a NU20-03-00285 $p Ministerstvo Zdravotnictví Ceské Republiky
- GRA __
- $a CZ.1.05/4.1.00/16.0337 $p Ministerstvo Školství, Mládeže a Tělovýchovy
- LZP __
- $a Pubmed-20220425
